ATE187453T1 - N-substituierte piperidinyl bicyclische benzoatderivate - Google Patents

N-substituierte piperidinyl bicyclische benzoatderivate

Info

Publication number
ATE187453T1
ATE187453T1 AT95933400T AT95933400T ATE187453T1 AT E187453 T1 ATE187453 T1 AT E187453T1 AT 95933400 T AT95933400 T AT 95933400T AT 95933400 T AT95933400 T AT 95933400T AT E187453 T1 ATE187453 T1 AT E187453T1
Authority
AT
Austria
Prior art keywords
6alkyl
substituted
halo
hydrogen
alk
Prior art date
Application number
AT95933400T
Other languages
English (en)
Inventor
Daele Georges Henri Paul Van
Jean-Paul Rene Marie A Bosmans
Den Keybus Frans Maria Alf Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE187453T1 publication Critical patent/ATE187453T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95933400T 1994-09-27 1995-09-19 N-substituierte piperidinyl bicyclische benzoatderivate ATE187453T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202792 1994-09-27
US45548695A 1995-05-31 1995-05-31

Publications (1)

Publication Number Publication Date
ATE187453T1 true ATE187453T1 (de) 1999-12-15

Family

ID=26136613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95933400T ATE187453T1 (de) 1994-09-27 1995-09-19 N-substituierte piperidinyl bicyclische benzoatderivate

Country Status (23)

Country Link
EP (1) EP0784620B1 (de)
JP (1) JP3953097B2 (de)
CN (1) CN1068880C (de)
AT (1) ATE187453T1 (de)
AU (1) AU699152B2 (de)
BR (1) BR9509036A (de)
CA (1) CA2200578C (de)
CZ (1) CZ289031B6 (de)
DE (1) DE69513846T2 (de)
DK (1) DK0784620T3 (de)
ES (1) ES2141383T3 (de)
FI (1) FI119640B (de)
GR (1) GR3032646T3 (de)
HU (1) HU218698B (de)
IL (1) IL115413A (de)
MY (1) MY113202A (de)
NO (1) NO313238B1 (de)
NZ (1) NZ293605A (de)
PL (1) PL182502B1 (de)
PT (1) PT784620E (de)
RU (1) RU2154064C2 (de)
WO (1) WO1996010027A1 (de)
ZA (1) ZA958081B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL345309A1 (en) * 1998-05-14 2001-12-03 Egyt Gyogyszervegyeszeti Gyar Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
ES2242940T3 (es) * 2002-01-16 2005-11-16 Janssen Pharmaceutica N.V. Prucaloprida n-oxido.
WO2005061483A2 (en) * 2003-12-23 2005-07-07 Bio-Medisinsk Innovasjon As Modulators of peripheral 5-ht receptors
WO2006012226A2 (en) 2004-06-24 2006-02-02 Incyte Corporation N-substituted piperidines and their use as pharmaceuticals
PT2404919E (pt) 2005-11-08 2013-10-22 Vertex Pharma Composto heterocíclico útil como um modulador de transportadores de cassete de ligação a atp
EP2164840A2 (de) 2007-05-09 2010-03-24 Vertex Pharmaceuticals Incorporated Modulatoren von cftr
CA2989620C (en) 2007-12-07 2022-05-03 Vertex Pharmaceuticals Incorporated Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
HUE049642T2 (hu) 2007-12-07 2020-09-28 Vertex Pharma 3-(6-(1-(2,2-Difluorbenzo[d][1,3]dioxol-5-il)-ciklopropánkarboxamido)-3-metilpiridin-2-il)-benzoesav szilárd formái
CA2716109C (en) 2008-02-28 2016-07-19 Vertex Pharmaceuticals Incorporated Heteroaryl derivatives as cftr modulators
TWI549950B (zh) * 2010-04-07 2016-09-21 維泰克斯製藥公司 ３－（６－（１－（２，２－二氟苯并［ｄ］［１，３］二氧雜環戊烯－５－基）環丙烷甲醯胺基）－３－甲基吡啶－２－基）苯甲酸之固體形式
ES2900353T3 (es) 2010-04-07 2022-03-16 Vertex Pharma Composiciones farmacéuticas de ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiriidin-2-il)benzoico y administración de las mismas
NZ727015A (en) 2012-01-25 2017-12-22 Vertex Pharma Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
CA2930199C (en) 2013-11-12 2022-10-25 Vertex Pharmaceuticals Incorporated Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases
HUE055423T2 (hu) 2014-11-18 2021-11-29 Vertex Pharma Eljárás nagy áteresztõképességû tesztelõ nagy teljesítményû folyadék-kromatográfia elvégzésére

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1593569A3 (ru) * 1982-07-30 1990-09-15 Janssen Pharmaceutica Nv Cпocoб пoлучehия пpoизboдhыx n-(3-гидpokcи-4-пипepидиhил)бehзamидa или иx kиcлotho-aддиtиbhыx coлeй
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
MX9702363A (es) 1997-10-31
NO971376D0 (no) 1997-03-24
EP0784620B1 (de) 1999-12-08
JPH10506118A (ja) 1998-06-16
HU218698B (hu) 2000-11-28
GR3032646T3 (en) 2000-06-30
CA2200578C (en) 2006-11-07
EP0784620A1 (de) 1997-07-23
CN1166171A (zh) 1997-11-26
BR9509036A (pt) 1997-10-14
ES2141383T3 (es) 2000-03-16
DK0784620T3 (da) 2000-05-22
HUT77173A (hu) 1998-03-02
CZ91897A3 (en) 1997-12-17
JP3953097B2 (ja) 2007-08-01
AU3608195A (en) 1996-04-19
FI971274A0 (fi) 1997-03-26
IL115413A (en) 2000-02-17
NZ293605A (en) 1998-07-28
WO1996010027A1 (en) 1996-04-04
DE69513846T2 (de) 2000-07-06
CZ289031B6 (cs) 2001-10-17
MY113202A (en) 2001-12-31
PT784620E (pt) 2000-05-31
PL319997A1 (en) 1997-09-01
CN1068880C (zh) 2001-07-25
FI119640B (fi) 2009-01-30
FI971274A7 (fi) 1997-03-26
NO971376L (no) 1997-05-05
CA2200578A1 (en) 1996-04-04
IL115413A0 (en) 1995-12-31
RU2154064C2 (ru) 2000-08-10
PL182502B1 (pl) 2002-01-31
DE69513846D1 (de) 2000-01-13
AU699152B2 (en) 1998-11-26
ZA958081B (en) 1997-03-26
NO313238B1 (no) 2002-09-02

Similar Documents

Publication Publication Date Title
DE69513846D1 (de) N-substituierte piperidinyl bicyclische benzoatderivate
ES449191A1 (es) Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina.
TW369526B (en) Diazabicyclic neurokinin antagonists
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
DE60040901D1 (de) Polyhydroxyalkanoat
YU69991A (sh) Derivati piridina
EA200100710A1 (ru) 4-(аминометил)пиперидинбензамиды для лечения желудочно-кишечных расстройств
DE69921994D1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
DK0479546T3 (da) Piperazinderivater
MY120248A (en) Water soluble azoles as broad-spectrum antifungals
DE69923444D1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
ATE171943T1 (de) Piperidin-verbindungen, ihre darstellung und ihre verwendung
PL322872A1 (en) Novel triazolones - inhibitors of b apolipoprotein synthesis
TW360653B (en) A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
DK1150974T3 (da) Heterocykliske derivater som inhibitor af faktor Xa
BG103395A (en) Derivatives of benzenesulphonamide and medicaments containing them
ATE178064T1 (de) Phenyl-oxo-alkyl-(4-piperidinyl) benzoatderivate
JO1648B1 (en) Nitrogen compounds
NO932513L (no) N-alkyl-kinuklidinium-salter

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee